Oncopharmpod

To Rechallenge, Or Not To Rechallenge

Informações:

Synopsis

Weighing the risks & benefits of immunotherapy rechallenge in patients with a prior immune-related adverse event (irAE). Reference: https://www.ncbi.nlm.nih.gov/pubmed/31461381